Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

320 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon.
Rodeheffer RJ, Rommer JA, Wigley F, Smith CR. Rodeheffer RJ, et al. Among authors: wigley f. N Engl J Med. 1983 Apr 14;308(15):880-3. doi: 10.1056/NEJM198304143081507. N Engl J Med. 1983. PMID: 6339921 Clinical Trial. No abstract available.
Controlled double-blind trial of dazoxiben and nifedipine in the treatment of Raynaud's phenomenon.
Ettinger WH, Wise RA, Schaffhauser D, Wigley FM. Ettinger WH, et al. Among authors: wigley fm. Am J Med. 1984 Sep;77(3):451-6. doi: 10.1016/0002-9343(84)90101-3. Am J Med. 1984. PMID: 6540986 Clinical Trial.
Acute effects of nifedipine on digital blood flow in human subjects with Raynaud's phenomenon: a double blind placebo controlled trial.
Wise RA, Malamet R, Wigley FM. Wise RA, et al. Among authors: wigley fm. J Rheumatol. 1987 Apr;14(2):278-83. J Rheumatol. 1987. PMID: 3298649 Clinical Trial.
Nicardipine in the treatment of Raynaud's phenomenon. Dissociation of platelet activation from vasospasm.
Wigley FM, Wise RA, Malamet R, Scott TE. Wigley FM, et al. Arthritis Rheum. 1987 Mar;30(3):281-6. doi: 10.1002/art.1780300306. Arthritis Rheum. 1987. PMID: 2952125 Clinical Trial.
Nifedipine in the treatment of Raynaud's phenomenon. Evidence for inhibition of platelet activation.
Malamet R, Wise RA, Ettinger WH, Wigley FM. Malamet R, et al. Among authors: wigley fm. Am J Med. 1985 Apr;78(4):602-8. doi: 10.1016/0002-9343(85)90402-4. Am J Med. 1985. PMID: 3157318 Clinical Trial.
Raynaud's phenomenon in older adults: diagnostic considerations and management.
Ling SM, Wigley FM. Ling SM, et al. Among authors: wigley fm. Drugs Aging. 1999 Sep;15(3):183-95. doi: 10.2165/00002512-199915030-00002. Drugs Aging. 1999. PMID: 10503811 Review.
Digital pressure-flow relationships in subjects with Raynaud's phenomenon.
Wise RA, Wigley FM, Malamet R. Wise RA, et al. Among authors: wigley fm. Angiology. 1985 Sep;36(9):596-602. doi: 10.1177/000331978503600902. Angiology. 1985. PMID: 4051252
Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis.
Peters-Golden M, Wise RA, Schneider P, Hochberg M, Stevens MB, Wigley F. Peters-Golden M, et al. Among authors: wigley f. Medicine (Baltimore). 1984 Jul;63(4):221-31. doi: 10.1097/00005792-198407000-00004. Medicine (Baltimore). 1984. PMID: 6738343
Symptoms of Raynaud's phenomenon in an inner-city African-American community: prevalence and self-reported cardiovascular comorbidity.
Gelber AC, Wigley FM, Stallings RY, Bone LR, Barker AV, Baylor I, Harris CW, Hill MN, Zeger SL, Levine DM. Gelber AC, et al. Among authors: wigley fm. J Clin Epidemiol. 1999 May;52(5):441-6. doi: 10.1016/s0895-4356(99)00015-3. J Clin Epidemiol. 1999. PMID: 10360339
Behavioral and pharmacologic interventions: the Raynaud's Treatment Study.
Thompson B, Geller NL, Hunsberger S, Frederick M, Hill R, Jacob RG, Smith EA, Kaufmann P, Freedman RR, Wigley FM, Bielory L. Thompson B, et al. Among authors: wigley fm. Control Clin Trials. 1999 Feb;20(1):52-63. doi: 10.1016/s0197-2456(98)00046-4. Control Clin Trials. 1999. PMID: 10027500 Clinical Trial.
320 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback